Lancet

The most recent articles from: Lancet November 2021

Lancet · Nov 2021

Comment

Transforming access to diagnostics: how to turn good intentions into action?

no abstract available

expand abstract… or not…
Lancet · Nov 2021

Department of Error.

no abstract available

read more… or not…
Lancet · Nov 2021

Department of Error.

no abstract available

keep reading… or not…
Lancet · Nov 2021

Department of Error.

no abstract available

read more… or just mark as read…
Lancet · Nov 2021

Randomized Controlled Trial

Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial.

Tofacitinib is an oral Janus kinase inhibitor. This trial assessed the efficacy and safety of tofacitinib versus placebo in patients with polyarticular course juvenile idiopathic arthritis (JIA). ⋯ Pfizer.

read more… or not…

1
2
3
4
5
6
7
8
9
…
21
22

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,694,794 articles already indexed!